BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 38473388)

  • 1. Integration of Ultrasound in Image-Guided Adaptive Brachytherapy in Cancer of the Uterine Cervix.
    Manea E; Chitoran E; Rotaru V; Ionescu S; Luca D; Cirimbei C; Alecu M; Capsa C; Gafton B; Prutianu I; Serban D; Simion L
    Bioengineering (Basel); 2024 May; 11(5):. PubMed ID: 38790373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose-Rate Three-Dimensional Image-Guided Adaptive Brachytherapy (3D IGABT) for Locally Advanced Cervical Cancer (LACC): A Narrative Review on Imaging Modality and Clinical Evidence.
    Wang K; Wang J; Jiang P
    Curr Oncol; 2023 Dec; 31(1):50-65. PubMed ID: 38275830
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent Advances and Adaptive Strategies in Image Guidance for Cervical Cancer Radiotherapy.
    Anghel B; Serboiu C; Marinescu A; Taciuc IA; Bobirca F; Stanescu AD
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Status and Future Directions of Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer.
    Eustace N; Liu J; Ladbury C; Tam A; Glaser S; Liu A; Chen YJ
    Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer.
    Smet S; Nesvacil N; Knoth J; Sturdza A; Najjari-Jamal D; Jelinek F; Kronreif G; Pötter R; Widder J; Kirisits C; Schmid MP
    Strahlenther Onkol; 2020 Nov; 196(11):983-992. PubMed ID: 32621011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
    Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
    Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
    Mahantshetty U; Naga Ch P; Khadanga CR; Gudi S; Chopra S; Gurram L; Jamema S; Ghadi Y; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1448-1456. PubMed ID: 30146092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TU-E-213CD-01: Image Guided Adaptive Brachytherapy for Cervical Cancer.
    Craciunescu O; Cai J; de Leeuw A; Kirisits C
    Med Phys; 2012 Jun; 39(6Part24):3913. PubMed ID: 28518703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining transrectal ultrasound and CT for image-guided adaptive brachytherapy of cervical cancer: Proof of concept.
    Nesvacil N; Schmid MP; Pötter R; Kronreif G; Kirisits C
    Brachytherapy; 2016; 15(6):839-844. PubMed ID: 27693172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes from a 3-fraction high-dose-rate brachytherapy regimen for patients with cervical cancer.
    Williamson CW; Kotha NV; Zou J; Brown D; Scanderbeg D; Rash D; Einck J; Yashar C; Mell LK; Mayadev J
    Brachytherapy; 2023; 22(3):317-324. PubMed ID: 36631374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing dosimetry of locally advanced cervical cancer patients treated with 3 versus 4 fractions of MRI-guided brachytherapy.
    Scott AA; Weersink M; Liu ZA; Milosevic M; Croke J; Fyles A; Lukovic J; Rink A; Beiki-Ardakani A; Borg J; Xie J; Chan K; Ballantyne H; Skliarenko J; Conway JL; Gladwish A; Weersink RA; Han K
    Brachytherapy; 2023; 22(2):146-156. PubMed ID: 36528475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-Dimensional Image-Guided Adaptive Brachytherapy for Cervical Cancer: A Systematic Review and Meta-Regression Analysis.
    Li F; Shi D; Bu M; Lu S; Zhao H
    Front Oncol; 2022; 12():870570. PubMed ID: 35860574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
    Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
    Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Tata Memorial Centre, India, to cervical cancer care: Journey of two decades.
    Kumar A; Chopra S; Gupta S
    Indian J Med Res; 2021 Aug; 154(2):319-328. PubMed ID: 35295006
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.